WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREVALENCE AND GENDER DISTRIBUTION OF THALASSEMIA TRAITS IN COUPLES UNDERGOING PREMARITAL SCREENING AT AL-MADAEN GENERAL HOSPITAL IN BAGHDAD-IRAQ

Dr. Bahaa Dawood Abdulkareem (M.B.Ch.B., C.A.B.H.S. /FM), Dr. Hiba Khalid Ali (M.B.Ch.B., F.I.C.M.S./Pathology)

ABSTRACT

Background: Thalassemia is a heterogeneous group of inherited hemoglobin disorders caused by quantitative defects in globin chain synthesis, resulting in chronic anemia of different severity. Thalassemia is a significant public health challenge in Iraq, preventive methods, particularly premarital screening programs, have been implemented to detect carriers early on and provide appropriate genetic counseling. Objectives: To determine the prevalence and gender distribution of thalassemia trait among couples undergoing premarital screening in Baghdad, Iraq. Methods: This is a descriptive cross-sectional study carried out during the period from 2nd of January 2024 till the 27th of December 2024 at Al-Madaen General hospital. All individuals with microcytic anemia who completed the premarital screening process and had complete hematological data were included in the study. Individuals with already known hemoglobinopathies, those with inadequate laboratory data, and those who declined to participate were excluded. Results: Among 998 screened individual (499) couples, 149 individuals were identified as having thalassemia trait, corresponding to an overall prevalence of 14.9%. The mean age ± standard deviation of the study participants is 25.87 ± 4.75 years. Within these couples, only male carrier was prevalent among 71 (14.23%), while female carrier was prevalent among 38 (7.26%) and both partner (high risk) among 20 (4%). Conclusion: Continuous use of specific screening approaches (such as microcytosis-based selection) in conjunction with traditional premarital screening. The study highlights the importance of improved hematological screening for identifying silent carriers and expanding genetic counseling reach.

[Full Text Article] [Download Certificate]